Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
6
×
clinical trials
fda
6
×
life sciences
national blog main
boston top stories
national top stories
new york blog main
new york top stories
san francisco blog main
san diego blog main
san diego top stories
san francisco top stories
biotech
boston
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
drugs
indiana blog main
indiana top stories
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
deals
investing
merck
national
pfizer
4d molecular therapeutics
abbvie
acne
agenus
What
approved
6
×
drug
fda
medicine
new
oks
specifically
therapeutics
time
treat
affects
afternoon
agency
aimmune
allergy
alnylam
alnylam’s
americans
approval
awarded
bio
brexanolone
cancer
companies
date
deeper
depression
devastating
developed
developing
digital
disease
disorder
dna
epidemic
fast
fatty
fingerprint
frenzied
frequency
Language
unset
Current search:
fda
×
" boston blog main "
×
approved
×
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug